US6218364B1
(en)
|
1988-06-20 |
2001-04-17 |
Scott L. Harbeson |
Fluorinated neurokinin A antagonists
|
US5830863A
(en)
*
|
1988-06-20 |
1998-11-03 |
Merrell Pharmaceuticals Inc. |
Neurokinin A antagonists
|
GB9023116D0
(en)
*
|
1990-10-24 |
1990-12-05 |
Fujisawa Pharmaceutical Co |
Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
|
US5420297A
(en)
*
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
DE69114117T2
(de)
*
|
1990-12-21 |
1996-03-21 |
Fujisawa Pharmaceutical Co |
Neue Verwendung von Peptidderivat.
|
US5610140A
(en)
*
|
1991-04-01 |
1997-03-11 |
Cortech, Inc. |
Bradykinin receptor antagonists with neurokinin receptor blocking activity
|
FR2677361A1
(fr)
*
|
1991-06-04 |
1992-12-11 |
Adir |
Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
GB9113219D0
(en)
*
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
WO1993001169A2
(en)
*
|
1991-07-05 |
1993-01-21 |
Merck Sharp & Dohme Limited |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
US5629347A
(en)
*
|
1991-07-05 |
1997-05-13 |
Merck Sharp & Dohme Ltd. |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
US5610183A
(en)
*
|
1991-07-10 |
1997-03-11 |
Merck, Sharp & Dohme Ltd. |
Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy
|
WO1993001159A1
(en)
*
|
1991-07-10 |
1993-01-21 |
Merck Sharp & Dohme Limited |
Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
|
PT533280E
(pt)
*
|
1991-09-20 |
2001-01-31 |
Glaxo Group Ltd |
Novas utilizacoes medicas para antagonistas de taquiquinina
|
FR2681864B1
(fr)
*
|
1991-09-27 |
1995-03-31 |
Adir |
Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5654400A
(en)
*
|
1991-10-04 |
1997-08-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Process for making peptide compounds having tachykinin antagonistic activity
|
GB9200535D0
(en)
*
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
US5328927A
(en)
*
|
1992-03-03 |
1994-07-12 |
Merck Sharpe & Dohme, Ltd. |
Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
|
IT1263116B
(it)
*
|
1992-04-09 |
1996-07-30 |
Rotta Research Lab |
Derivati basici dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso farmaceutico
|
US5444074A
(en)
*
|
1992-04-15 |
1995-08-22 |
Merck Sharp & Dohme Limited |
Piperidine tachykinin receptor antagonists
|
GB9211193D0
(en)
*
|
1992-05-27 |
1992-07-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5612336A
(en)
*
|
1992-07-13 |
1997-03-18 |
Merck, Sharp & Dohme Ltd. |
Heterocyclic amide derivatives as tachykinin antagonists
|
GB9216911D0
(en)
*
|
1992-08-10 |
1992-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE69329712T2
(de)
*
|
1992-08-13 |
2001-04-12 |
Warner Lambert Co |
Tachykinin antagonistes
|
DE4243496A1
(de)
*
|
1992-09-03 |
1994-03-10 |
Boehringer Ingelheim Kg |
Neue Dipeptidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
ATE186548T1
(de)
*
|
1992-09-03 |
1999-11-15 |
Boehringer Ingelheim Pharma |
Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
|
US5563161A
(en)
*
|
1992-09-10 |
1996-10-08 |
Merck Sharp & Dohme Ltd. |
Alcohols and ethers with aromatic substituents as tachykinin-antagonists
|
US5554627A
(en)
*
|
1992-10-30 |
1996-09-10 |
Merck, Sharp & Dohme Ltd. |
Tachykinin antagonists
|
IT1256623B
(it)
*
|
1992-12-04 |
1995-12-12 |
Federico Arcamone |
Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
|
US5830854A
(en)
*
|
1992-12-14 |
1998-11-03 |
Merck Sharp & Dohme, Limited |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
|
GB9300051D0
(en)
*
|
1993-01-04 |
1993-03-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
FR2700472B1
(fr)
|
1993-01-19 |
1995-02-17 |
Rhone Poulenc Rorer Sa |
Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2.
|
GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5496833A
(en)
*
|
1993-04-13 |
1996-03-05 |
Merck Sharp & Dohme Limited |
Piperidine tachykinin receptor antagonists
|
WO1995000536A1
(en)
*
|
1993-06-22 |
1995-01-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptide compounds
|
US6869957B1
(en)
|
1993-11-17 |
2005-03-22 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
ITFI940009A1
(it)
*
|
1994-01-19 |
1995-07-19 |
Menarini Farma Ind |
Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono.
|
DE69519182T2
(de)
*
|
1994-03-17 |
2001-05-17 |
Fujirebio Kk |
Azapeptid-Derivate
|
FR2719312B1
(fr)
*
|
1994-04-28 |
1996-06-14 |
Adir |
Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
|
US5597845A
(en)
*
|
1994-06-20 |
1997-01-28 |
Merrell Pharmaceuticals Inc. |
Substituted alkyldiamine derivatives
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
US5491140A
(en)
*
|
1994-06-30 |
1996-02-13 |
Eli Lilly And Company |
Naphthyl tachykinin receptor antagonists to treat physiological conditions
|
GB9418545D0
(en)
*
|
1994-09-15 |
1994-11-02 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5932737A
(en)
*
|
1994-12-02 |
1999-08-03 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptide compounds for treatment of no-mediated diseases
|
IL116323A0
(en)
*
|
1994-12-13 |
1996-03-31 |
Sandoz Ag |
Tachykinin antagonists their preparation and pharmaceutical compositions containing them
|
FR2728166A1
(fr)
|
1994-12-19 |
1996-06-21 |
Oreal |
Composition topique contenant un antagoniste de substance p
|
FR2728169A1
(fr)
|
1994-12-19 |
1996-06-21 |
Oreal |
Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
|
FR2728165A1
(fr)
|
1994-12-19 |
1996-06-21 |
Oreal |
Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
|
FR2732221B1
(fr)
*
|
1995-03-28 |
1997-04-25 |
Oreal |
Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
|
WO1996035711A1
(en)
*
|
1995-05-10 |
1996-11-14 |
Chiroscience Limited |
Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
|
KR100241643B1
(ko)
*
|
1995-06-06 |
2000-03-02 |
디. 제이. 우드 |
당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
|
DE19541283A1
(de)
*
|
1995-11-06 |
1997-05-07 |
Boehringer Ingelheim Kg |
Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
FR2741262B1
(fr)
|
1995-11-20 |
1999-03-05 |
Oreal |
Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
AU5330698A
(en)
|
1996-12-23 |
1998-07-17 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
GB9705361D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
WO1998054207A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
EP1056714B1
(de)
*
|
1998-02-26 |
2004-08-11 |
Celltech Therapeutics Limited |
Phenylalaninderivate als inhibitoren von alpha4 integrinen
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9811969D0
(en)
*
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9812088D0
(en)
|
1998-06-05 |
1998-08-05 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
IT1304898B1
(it)
*
|
1998-09-08 |
2001-04-05 |
Menarini Ricerche Spa |
Prodotti con caratteristiche basiche aventi attivita' antagonista sulrecettore nk-1 e loro impiego in preparazioni farmaceutiche
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6518283B1
(en)
*
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
GB9924862D0
(en)
*
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EP1246806B1
(de)
|
1999-11-03 |
2008-02-27 |
AMR Technology, Inc. |
Arly- und heteroaryl-substituierte tetrahydroisoquinoline und ihre verwendung als hemmer der wiederaufnahme von norepinephrin, dopamin und serotonin
|
US7163949B1
(en)
|
1999-11-03 |
2007-01-16 |
Amr Technology, Inc. |
4-phenyl substituted tetrahydroisoquinolines and use thereof
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
US6653304B2
(en)
*
|
2000-02-11 |
2003-11-25 |
Bristol-Myers Squibb Co. |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
|
US20020001805A1
(en)
*
|
2000-03-14 |
2002-01-03 |
Roden Richard Bruce |
Immunogenic ovarian cancer genes
|
ATE375330T1
(de)
|
2000-04-17 |
2007-10-15 |
Ucb Pharma Sa |
Enamin-derivate als zell-adhäsionsmoleküle
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
WO2002004426A1
(en)
|
2000-07-07 |
2002-01-17 |
Celltech R & D Limited |
Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
|
WO2002004455A2
(en)
|
2000-07-11 |
2002-01-17 |
Albany Molecular Research, Inc |
4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
|
EP1305291A1
(de)
|
2000-08-02 |
2003-05-02 |
Celltech R&D Limited |
3-substituierte isochinolin-1-yl-derivate
|
CN100480242C
(zh)
*
|
2001-05-29 |
2009-04-22 |
舍林股份公司 |
Cdk抑制性嘧啶化合物、其制备方法以及作为药物的应用
|
PT1397130E
(pt)
*
|
2001-06-20 |
2007-11-13 |
Wyeth Corp |
Derivados ácidos de indole substituído como inibidores de inibidor 1 do activador de plasminogénio (pai-1)
|
TWI224101B
(en)
*
|
2001-06-20 |
2004-11-21 |
Wyeth Corp |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
|
US6709651B2
(en)
|
2001-07-03 |
2004-03-23 |
B.M.R.A. Corporation B.V. |
Treatment of substance P-related disorders
|
IL145926A0
(en)
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
MY130373A
(en)
|
2001-10-29 |
2007-06-29 |
Malesci Sas |
Linear basic compounds having nk-2 antagonist activity and formulations thereof
|
UA80453C2
(en)
*
|
2002-12-10 |
2007-09-25 |
|
Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
DK1569900T3
(da)
*
|
2002-12-10 |
2006-10-23 |
Wyeth Corp |
Substituerede 3-carbonyl-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
|
US7348351B2
(en)
*
|
2002-12-10 |
2008-03-25 |
Wyeth |
Substituted 3-alkyl and 3-arylalkyl 1H-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
|
AU2003296324A1
(en)
*
|
2002-12-10 |
2004-06-30 |
Wyeth |
Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
EP2666772B1
(de)
*
|
2002-12-20 |
2017-03-01 |
Basf Se |
Synthese von Aminen und Zwischenverbindungen für die Synthese davon
|
IL155136A0
(en)
|
2003-02-10 |
2003-10-31 |
Enzymotec Ltd |
A composition for reducing blood cholesterol and triglycerides
|
US20060233863A1
(en)
|
2003-02-10 |
2006-10-19 |
Enzymotec Ltd. |
Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
|
FR2851471B1
(fr)
*
|
2003-02-24 |
2006-07-28 |
Synt Em |
Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison
|
US7268159B2
(en)
*
|
2003-09-25 |
2007-09-11 |
Wyeth |
Substituted indoles
|
US7442805B2
(en)
*
|
2003-09-25 |
2008-10-28 |
Wyeth |
Substituted sulfonamide-indoles
|
US7351726B2
(en)
*
|
2003-09-25 |
2008-04-01 |
Wyeth |
Substituted oxadiazolidinediones
|
US7582773B2
(en)
*
|
2003-09-25 |
2009-09-01 |
Wyeth |
Substituted phenyl indoles
|
US7420083B2
(en)
*
|
2003-09-25 |
2008-09-02 |
Wyeth |
Substituted aryloximes
|
US7534894B2
(en)
*
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US7342039B2
(en)
*
|
2003-09-25 |
2008-03-11 |
Wyeth |
Substituted indole oximes
|
US7332521B2
(en)
*
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
US7141592B2
(en)
*
|
2003-09-25 |
2006-11-28 |
Wyeth |
Substituted oxadiazolidinediones
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
US7163954B2
(en)
*
|
2003-09-25 |
2007-01-16 |
Wyeth |
Substituted naphthyl benzothiophene acids
|
US7446201B2
(en)
*
|
2003-09-25 |
2008-11-04 |
Wyeth |
Substituted heteroaryl benzofuran acids
|
US7265148B2
(en)
*
|
2003-09-25 |
2007-09-04 |
Wyeth |
Substituted pyrrole-indoles
|
AU2004303594A1
(en)
*
|
2003-12-23 |
2005-07-07 |
Wyeth |
Isopeptide gap junction modulators
|
KR101389246B1
(ko)
|
2004-07-15 |
2014-04-24 |
브리스톨-마이어스스퀴브컴파니 |
아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
|
CN101035594B
(zh)
*
|
2004-08-09 |
2013-10-23 |
酶学技术有限公司 |
用于糖尿病患者的食品
|
JP5118965B2
(ja)
|
2004-08-10 |
2013-01-16 |
エンジモテック リミテッド |
植物成分を必要とする治療方法
|
CA2577782A1
(en)
*
|
2004-08-23 |
2006-03-02 |
Wyeth |
Pyrrolo-naphthyl acids as pai-1 inhibitors
|
JP2008510816A
(ja)
*
|
2004-08-23 |
2008-04-10 |
ワイス |
チアゾロ−ナフチル酸
|
BRPI0514544A
(pt)
*
|
2004-08-23 |
2008-06-17 |
Wyeth Corp |
ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1)
|
US8362075B2
(en)
|
2005-05-17 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Cyclohexyl sulphones for treatment of cancer
|
EP1896500A4
(de)
*
|
2005-06-28 |
2010-08-11 |
Yeda Res & Dev |
Gliomedin, fragmente davon und verfahren zu ihrer anwendung
|
KR101594898B1
(ko)
|
2005-07-15 |
2016-02-18 |
알바니 몰레큘라 리써치, 인크. |
아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
|
US7683091B2
(en)
*
|
2005-08-17 |
2010-03-23 |
Wyeth |
Substituted indoles and methods of their use
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
GEP20115337B
(en)
|
2007-01-10 |
2011-11-25 |
St Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
|
EP2117538A1
(de)
|
2007-01-24 |
2009-11-18 |
Glaxo Group Limited |
Pharmazeutische zusammensetzungen mit 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
|
WO2008142693A2
(en)
*
|
2007-05-22 |
2008-11-27 |
Yeda Research And Development Co. Ltd. |
Regulation of myelination by nectin-like (necl) molecules
|
US8389553B2
(en)
|
2007-06-27 |
2013-03-05 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
AR071997A1
(es)
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
UA105182C2
(ru)
|
2008-07-03 |
2014-04-25 |
Ньюрексон, Інк. |
Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
EA020553B1
(ru)
|
2009-05-12 |
2014-12-30 |
Олбани Молекьюлар Рисерч, Инк. |
7-([1,2,4]ТРИАЗОЛО[1,5-α]ПИРИДИН-6-ИЛ)-4-(3,4-ДИХЛОРФЕНИЛ)-1,2,3,4-ТЕТРАГИДРОИЗОХИНОЛИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИЧЕСКИХ РАССТРОЙСТВ
|
WO2010132437A1
(en)
|
2009-05-12 |
2010-11-18 |
Albany Molecular Research, Inc. |
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
|
JP5739415B2
(ja)
|
2009-05-12 |
2015-06-24 |
ブリストル−マイヤーズ スクウィブ カンパニー |
(S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
|
MX2012004377A
(es)
|
2009-10-14 |
2012-06-01 |
Merck Sharp & Dohme |
Piperidinas sustituidas que aumentan la actividad de p53 y sus usos.
|
EP2601293B1
(de)
|
2010-08-02 |
2017-12-06 |
Sirna Therapeutics, Inc. |
Rna-interferenz-vermittelte hemmung der catenin (cadherin-assoziiertes protein)-beta-1 (ctnnb1)- genexpression mittels kurzer interferierender nukleinsäuren (sina)
|
AU2011292261B2
(en)
|
2010-08-17 |
2015-05-14 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
|
EP2608669B1
(de)
|
2010-08-23 |
2016-06-22 |
Merck Sharp & Dohme Corp. |
Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer
|
EP2613782B1
(de)
|
2010-09-01 |
2016-11-02 |
Merck Sharp & Dohme Corp. |
Indazolderivate als erk-hemmer
|
EP2615916B1
(de)
|
2010-09-16 |
2017-01-04 |
Merck Sharp & Dohme Corp. |
Kondensierte pyrazolderivate als neue erk-hemmer
|
EP3327125B1
(de)
|
2010-10-29 |
2020-08-05 |
Sirna Therapeutics, Inc. |
Rna-interferenz-vermittelte inhibition von genexpression unter verwendung kurzer interferierender nukleinsäure (sina)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
EA023259B1
(ru)
|
2011-01-04 |
2016-05-31 |
Новартис Аг |
Индольные соединения или их аналоги, полезные для лечения возрастной макулярной дегенерации (amd)
|
US20140045832A1
(en)
|
2011-04-21 |
2014-02-13 |
Piramal Enterprises Limited |
Insulin-Like Growth Factor-1 Receptor Inhibitors
|
WO2013063214A1
(en)
|
2011-10-27 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
EP3453762B1
(de)
|
2012-05-02 |
2021-04-21 |
Sirna Therapeutics, Inc. |
Sina-zusammensetzungen
|
US9815819B2
(en)
|
2012-06-28 |
2017-11-14 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
US9464081B2
(en)
|
2012-06-28 |
2016-10-11 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
ES2647124T3
(es)
|
2012-06-28 |
2017-12-19 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
ES2644700T3
(es)
|
2012-06-28 |
2017-11-30 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
ES2712190T3
(es)
|
2012-06-28 |
2019-05-09 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
JP6238980B2
(ja)
|
2012-07-12 |
2017-11-29 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
MX2015004041A
(es)
|
2012-09-28 |
2015-07-06 |
Merck Sharp & Dohme |
Compuestos novedosos que son inhibidores de erk.
|
RU2660349C2
(ru)
|
2012-11-28 |
2018-07-05 |
Мерк Шарп И Доум Корп. |
Композиции и способы для лечения злокачественной опухоли
|
US8846657B2
(en)
|
2012-12-20 |
2014-09-30 |
Merck Sharp & Dohme Corp. |
Substituted imidazopyridines as HDM2 inhibitors
|
EP2951180B1
(de)
|
2013-01-30 |
2018-05-02 |
Merck Sharp & Dohme Corp. |
2,6,7,8-substituierte purine als hdm2-inhibitoren
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
JP6687238B2
(ja)
|
2013-12-27 |
2020-04-22 |
株式会社エーピーアイ コーポレーション |
5−ヒドロキシピペリジン−2−カルボン酸の製造方法
|
WO2016118632A1
(en)
|
2015-01-20 |
2016-07-28 |
The General Hospital Corporation |
Prevention and treatment of itch with an mrgpr antagonist
|
EP3706742B1
(de)
|
2017-11-08 |
2023-03-15 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
US11993602B2
(en)
|
2018-08-07 |
2024-05-28 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
WO2020033284A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
AR122446A1
(es)
*
|
2020-04-29 |
2022-09-14 |
Medimmune Llc |
Composiciones y métodos para suministrar agentes farmacéuticamente activos
|
WO2023178107A2
(en)
*
|
2022-03-14 |
2023-09-21 |
The Research Foundation For The State University Of New York |
Orthogonally crosslinked proteins, methods of making, and uses thereof
|